Search results
15 wrz 2020 · Survival has improved, but varies widely by GPA for patients with non–small-cell lung, breast, melanoma, GI, and renal cancer with brain metastases from 7-47 months, 3-36 months, 5-34 months, 3-17 months, and 4-35 months, respectively.
- PDF
PURPOSEConventional wisdom has rendered patients with brain...
- Journal of Clinical Oncology
Sex-Based Differences in Risk of Therapy-Related Myeloid...
- PDF
13 kwi 2021 · Patients with a good prognosis may undergo SRS, WBRT, and/or surgical resection, while best supportive care with or without WBRT has been recommended for patients with a life expectancy of < 3...
26 paź 2023 · In the present analysis, brain metastasectomy, KPS, and available systemic therapy were demonstrated to be helpful clinical factors in guiding the discussion about the benefits of applying WBRT, which highlights the importance of tumor boards in the treatment of patients with cancer.
22 maj 2023 · Proton therapy was significantly associated with a reduced risk of hypothyroidism, hormone deficiency, reduced need for endocrine replacement therapy and greater height standard deviation score amongst matched cohorts of medulloblastoma survivors treated with photon therapy .
Proton therapy uses proton particles, which can be set to travel a specific distance into the brain tumor before they stop. This makes it possible for doctors to target just the tumor while minimizing radiation dose to sensitive brain tissues and structures around it.
12 sie 2023 · Radiotherapy for brain metastasis and long-term survival. Article Open access 13 April 2021. Introduction. Stereotactic radiosurgery (SRS) is the most preferred treatment modality for brain...
27 paź 2023 · Proton beam therapy precisely targets brain tumors, allowing for the delivery of higher doses of radiation. The treatment is especially useful for tumors in children and tumors near eloquent brain tissue.
